Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add more filters










Database
Language
Publication year range
1.
J Dent Res ; 93(2): 109-16, 2014 Feb.
Article in English | MEDLINE | ID: mdl-24088412

ABSTRACT

The bone-regenerative potentials of the periosteum have been explored as early as the 17th century. Over the past few years, however, much has been discovered in terms of the molecular and cellular mechanisms that control the periosteal contribution to bone regeneration. Lineage tracing analyses and knock-in transgenic mice have helped define the relative contributions of the periosteum and endosteum to bone regeneration. Additional studies have shed light on the critical roles that BMP, FGF, Hedgehog, Notch, PDGF, Wnt, and inflammation signaling have or may have in periosteal-mediated bone regeneration, fostering the path to novel approaches in bone-regenerative therapy. Thus, by examining the role that each pathway has in periosteal-mediated bone regeneration, in this review we analyze the status of the current research on the regenerative potential of the periosteum. The provided analysis aims to inform both clinician-scientists who may have interest in the current studies about the biology of the periosteum as well as dental surgeons who may find this review useful to perform periosteal-harnessing bone-regenerative procedures.


Subject(s)
Bone Regeneration/physiology , Facial Bones/physiology , Periosteum/physiology , Skull/physiology , Animals , Biology , Cell Lineage/physiology , Humans , Intercellular Signaling Peptides and Proteins/physiology , Periosteum/anatomy & histology , Signal Transduction/physiology , Tissue Engineering/methods
2.
Pharmacotherapy ; 5(2): 95-107, 1985.
Article in English | MEDLINE | ID: mdl-3889871

ABSTRACT

Cardiac electrophysiology studies use intracardiac recording and programmed stimulation to define the mechanisms and most appropriate therapy for supraventricular and ventricular arrhythmias. Using these techniques, the majority of clinical tachycardias can be reproducibly initiated and terminated in the electrophysiology laboratory, thereby allowing the most appropriate therapy to be selected. With this approach, antiarrhythmic agents can be tested in a systematic, serialized fashion for efficacy, safety and patient tolerance. With both supraventricular and ventricular tachycardias, suppression of arrhythmia induction predicts freedom from recurrence, whereas inducibility carries a poor prognosis in clinical follow-up. Electrophysiology studies provide a safe and effective approach to the treatment of selected patients with cardiac arrhythmias.


Subject(s)
Anti-Arrhythmia Agents/therapeutic use , Arrhythmias, Cardiac/drug therapy , Electrocardiography , Arrhythmias, Cardiac/physiopathology , Atrioventricular Node/physiopathology , Cardiac Catheterization , Cardiac Pacing, Artificial , Drug Evaluation , Humans , Tachycardia/physiopathology , Wolff-Parkinson-White Syndrome/physiopathology
SELECTION OF CITATIONS
SEARCH DETAIL
...